Philikos Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Philikos General Information

Description

Developer of antibody-based therapies designed to treat severe immune disorders. The company platform offers a compound, T-Guard, which rebalances the immune system by depleting activated T cells and NK cells, enabling patients with conditions like scleroderma to achieve restored immune function and improved long-term health outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Molenveldlaan 100
  • 6523 RN Nijmegen
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Molenveldlaan 100
  • 6523 RN Nijmegen
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Philikos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 23-Dec-2024 Completed Generating Revenue
To view Philikos’s complete valuation and funding history, request access »

Philikos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Philikos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Oost NL Venture Capital Minority
Radboud University University Minority
To view Philikos’s complete investors history, request access »

Philikos FAQs

  • When was Philikos founded?

    Philikos was founded in 2023.

  • Where is Philikos headquartered?

    Philikos is headquartered in Nijmegen, Netherlands.

  • What is the size of Philikos?

    Philikos has 1 total employees.

  • What industry is Philikos in?

    Philikos’s primary industry is Drug Discovery.

  • Is Philikos a private or public company?

    Philikos is a Private company.

  • What is Philikos’s current revenue?

    The current revenue for Philikos is .

  • Who are Philikos’s investors?

    Oost NL and Radboud University have invested in Philikos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process